Table 1.
Demographic and clinical characteristics of PWE enrolled in the study (N = 120).
| N (%) | ||
|---|---|---|
| Gender | Male | 58 (48.3) |
| Female | 62 (51.7) | |
| Age of onset | >10 years | 83 (69.2) |
| <10 years | 37 (30.8) | |
| Disease duration | <10 years | 25 (20.8) |
| >10 years | 95 (79.2) | |
| Epilepsy type/syndrome | Focal epilepsy | 85 (70.8) |
| Idiopathic generalized epilepsy | 32 (26.7) | |
| Epileptic encephalopathy | 3 (2.5) | |
| Etiology of focal epilepsy | Structural or symptomatic | 42 (35) |
| Unknown/idiopathic | 43 (35.8) | |
| Lobar involvement in focal epilepsy | Temporal | 39 (46) |
| Extra-temporal | 46 (54) | |
| Therapy regimen | Polytherapy | 81 (67.5) |
| Monotherapy | 37 (30.8) | |
| None | 2 (1.7) | |
| ASM generation | 1st generation | 85 (70.8) |
| 2nd/3rd generation | 33 (27.5) | |
| Drug-resistance | Total | 71 (59.2) |
| Focal | 56 (46.7) | |
| Generalized | 12 (10) | |
| Epileptic encephalopathy | 3 (2.5) | |
| Seizure rate in drug-resistant epilepsies | Annual/monthly | 34 (28.3) |
| Weekly/daily | 37 (30.8) |
ASM, antiseizure medication; PWE, patients with epilepsy.